BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17504301)

  • 1. Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.
    Jeong EG; Lee SH; Yoo NJ; Lee SH
    APMIS; 2007 Apr; 115(4):341-6. PubMed ID: 17504301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of caspase 1, 4, and 5 genes in common human cancers.
    Soung YH; Jeong EG; Ahn CH; Kim SS; Song SY; Yoo NJ; Lee SH
    Hum Pathol; 2008 Jun; 39(6):895-900. PubMed ID: 18430458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of PTPRT phosphatase domains in common human cancers.
    Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
    Ahmad F; Mandava S; Das BR
    Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of caspase-14 gene in common carcinomas.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of MYC in common epithelial cancers and acute leukemias.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Jun; 114(6):436-9. PubMed ID: 16856965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the kinase domain of MYLK2 gene in common human cancers.
    Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Pathol Res Pract; 2006; 202(3):137-40. PubMed ID: 16448786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell line.
    Chi HT; Vu HA; Iwasaki R; Nagamura F; Tojo A; Watanabe T; Sato Y
    Leuk Res; 2010 Feb; 34(2):261-2. PubMed ID: 19854508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
    Falini B; Sportoletti P; Martelli MP
    Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia.
    Scholl S; Mügge LO; Landt O; Loncarevic IF; Kunert C; Clement JH; Höffken K
    Leuk Res; 2007 Sep; 31(9):1205-11. PubMed ID: 17306368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the ARAF gene in human cancers.
    Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Min WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2005 Jan; 113(1):54-7. PubMed ID: 15676015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of NPM1 gene mutations in acute myeloid leukemia].
    Yan LZ; Chen SN; Liang JY; Feng YF; Cen JN; He J; Chang WR; Zhu ZL; Pan JL; Wu YF; Xue YQ; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):289-93. PubMed ID: 17877154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.
    Ruan GR; Li JL; Qin YZ; Li LD; Xie M; Chang Y; Zhang Y; Liu YR; Jiang B; Chen SS; Huang XJ
    Ann Hematol; 2009 Feb; 88(2):159-66. PubMed ID: 18726096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
    Falini B
    Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.